Assisted Reproductive Technology Market - Global Size, Share, Trends, Growth and Forecast Year ( 2022 – 2032 )

Assisted Reproductive Technology Market

Assisted Reproductive Technology Market by Type ((IVF), (ICSI), (GIFT), (FET), Others), Technology (Fresh ART Cycles, Frozen ART Cycles, Donor ART Cycles, Autologous ART Cycles), End-use Industry (Fertility Clinics, Hospitals, and Surgical Centers, Research and Academic Institutes), and Geographic Regions (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa): Industry Trends and Global Forecasts, 2023-2032

Market Size and Overview:

According to KD Market Insights, the global assisted reproductive technology market size was valued at USD 3.1 billion in 2022 and is estimated to reach USD 16.9 billion by 2032, growing at a CAGR of 19.3% from 2023 to 2032. The assisted reproductive technology (ART) market involves various medical procedures and technologies that assist couples and individuals in achieving pregnancy. These techniques are utilized when natural conception is not possible or when individuals face fertility challenges.

Assisted Reproductive Technology Market Segmentation

The segments assisted reproductive technology (ART) market are:

By Procedure Type:

• In Vitro Fertilization (IVF)
• Intracytoplasmic Sperm Injection (ICSI)
• Gamete Intrafallopian Transfer (GIFT)
• Frozen Embryo Transfer (FET)
• Others

By Technology:

• Fresh ART Cycles
• Frozen ART Cycles
• Donor ART Cycles
• Autologous ART Cycles

By End User:

• Fertility Clinics
• Hospitals and Surgical Centers
• Research and Academic Institutes

By Geography:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

The In Vitro Fertilization (IVF) procedure segment is the leading segment of the Assisted Reproductive Technology (ART) market. IVF is a widely adopted and well-established ART fashion that involves the retrieval of eggs from the ovaries, fertilization in a laboratory setting, and the transfer of resulting embryos into the uterus. IVF is used to address various causes of infertility, such as tubal blockages, manly factor infertility, endometriosis, and unexplained infertility.

Assisted Reproductive Technology Market Regional Synopsis

The ART market in North America, particularly in the United States, is well-established and advanced. It benefits from a robust healthcare infrastructure, high awareness about fertility treatments, and favorable reimbursement policies. The region has a significant number of fertility conventions and research institutions, driving advancements in ART technologies and procedures.

Europe is a prominent market for ART, with countries like Germany, France, the United Kingdom, and Spain leading the way. The region has a strong regulatory framework governing ART procedure and is known for its high-quality healthcare services.

The Asia Pacific region is witnessing significant growth in the ART market. Countries like China, India, Japan, and Australia are showcasing an increase in demand for fertility treatments due to factors such as changing lifestyles, delayed parenting, and improving healthcare access.

The ART market in Latin America is developing steadily, with countries such as Brazil, Mexico, and Argentina at the forefront. The region's growing middle-class population, increasing awareness about fertility treatments, and improving healthcare infrastructure are driving the demand for ART procedures. However, the market still faces challenges related to affordability and access to advanced ART technologies.

The ART market in the Middle East and Africa region is gradationally expanding. Countries like the United Arab Emirates, South Africa, and Egypt have witnessed growth in fertility clinics and the adoption of ART procedures. However, cultural, and religious factors can influence the acceptance and availability of certain ART techniques in this region.

Assisted Reproductive Technology Market Driving Factors

The rising prevalence of infertility due to factors such as age, lifestyle changes, and medical conditions is a significant driving force behind the ART market. As more individuals and couples face challenges in conceiving naturally, the demand for ART procedures, such as IVF, ICSI, and doner ART, continues to grow.

Technological advancements in the field of reproductive medicine have improved the success rates and accessibility of ART procedures. Innovations in techniques such as embryo culture, genetic testing, cryopreservation, and assisted hatching have contributed to higher pregnancy rates and better outcomes, driving the adoption of ART.

Individuals and couples globally are becoming more aware of and accepting of ART. Media coverage, educational campaigns, and increased public discourse have helped to reduce the stigma around infertility and ART treatments. As a result, greater acceptance, and utilization of ART services.

The demand for ART has been influenced by changing socioeconomic trends, such as delayed parenthood and career-oriented lifestyle. More people and couples who decide to have children later in life may receive support from ART procedures to overcome age-related reproductive problems.

Assisted Reproductive Technology Market challenges

ART procedures can be expensive, often requiring multiple cycles, medications, and laboratory services. The high cost of ART treatments can be a significant barrier for many individuals and couples, limiting their access to these services.

 ART involves complex ethical and legal considerations, including issues related to the use of donor gametes or embryos, surrogacy, and the selection of certain traits through preimplantation genetic testing. These ethical and legal challenges vary across different regions and can impact the availability and acceptance of certain ART procedures.

Insurance coverage for ART treatments can be limited or non-existent in many regions. The lack of comprehensive insurance coverage places a financial burden on patients and may restrict their ability to pursue ART options.

Assisted Reproductive Technology Market Key Players

Some prominent key players in assisted reproductive technology (ART) market are:

• CooperSurgical, Inc.
• Vitrolife AB
• Merck KGaA
• Ferring Pharmaceuticals
• Cook Medical
• Irvine Scientific
• Thermo Fisher Scientific, Inc.
• Genea Limited
• OvaScience, Inc.
• INVO Bioscience
• Other Players

On June 2, 2022, Inception Fertility (Inception) had expanded its ecosystem to include the launch of Haven Cryo a long-term reproductive tissue and cryopreservation storage solution that offers a unique experience for fertility providers and patients.